Additional MOUNJARO-dealt with patients who produced anti-tirzepatide antibodies seasoned hypersensitivity reactions or injection site reactions than people who did not establish these antibodies [see ADVERSE REACTIONS ].Tirzepatide can be a GIP receptor and GLP-1 receptor agonist. It's really a 39-amino-acid modified peptide by using a C20 fatty d